Literature DB >> 404553

Ketoacidosis in pancreatectomized man.

A J Barnes, S R Bloom, K Goerge, G M Alberti, P Smythe, F P Alford, D J Chisholm.   

Abstract

We investigated the importance of glucagon in the development of diabetic ketoacidosis by withholding insulin from six patients with juvenile-type diabetes and four totally pancreatectomized subjects. Patients were fasting and had previously been maintained on intravenous insulin for 24 hours. In diabetic patients plasma glucagon concentrations rose sharply after withdrawal of insulin, and the increases were accompanied by a rise in blood ketone concentration of 4.1+/-0.7 (S.E.M.) and blood glucose concentration of 12.5+/-1.8 mmol per liter by 12 hours. In the pancreatectomized patients, despite the absence of measurable glucagon, blood ketones rose by 1.8+/-0.8 and blood glucose by 7.7+/-1.5 mmol per liter. Thus, glucagon is not essential for the development of ketoacidosis in diabetes, as has previously been suggested, but it may accelerate the onset of ketonemia and hyperglycemia in situations of insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404553     DOI: 10.1056/NEJM197706022962202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

Review 2.  The alpha-cell as target for type 2 diabetes therapy.

Authors:  Mikkel Christensen; Jonatan I Bagger; Tina Vilsbøll; Filip K Knop
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 3.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

Review 4.  Progress in myasthenia gravis.

Authors:  C W Havard
Journal:  Br Med J       Date:  1977-10-15

5.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

6.  A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.

Authors:  A J Scheen; G Krzentowski; M Castillo; P J Lefèbvre; A S Luyckx
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

7.  Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.

Authors:  J C Pickup; G C Viberti; R W Bilous; H Keen; K G Alberti; P D Home; C Binder
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

8.  Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man.

Authors:  G E Sonnenberg; W Stauffacher; U Keller
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

9.  Management of secondary diabetes mellitus after total pancreatectomy in infancy.

Authors:  S A Greene; A Aynsley-Green; G Soltesz; J D Baum
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

10.  Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects.

Authors:  J K Nicholson; M P O'Flynn; P J Sadler; A F Macleod; S M Juul; P H Sönksen
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.